Dulac Edward J III
SEC CIK 1821530 · EDGAR
BoughtSold
Most active insiders at NTLA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| 2 | Cohen Fred E | Dir | $1.40M | — |
| 3 | Dulac Edward J III | EVP, CFO | — | $234.2K |
| 4 | BASTA JAMES | EVP, GC | — | $112.4K |
| 5 | Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| 6 | Dube Michael P | VP, CAO | — | $104.4K |
| 7 | Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| 8 | Schultes Birgit C | EVP, CSO | — | $78.9K |
| 9 | Bhanji Muna | Dir | — | — |
| 10 | Keresty Georgia | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-24 17:26 | 2026-07-22 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | S - Sale | $11.25 | -8,111 | 148.2K | -5% | -$91.2K | |
| T | 2026-07-06 17:01 | 2026-07-02 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | S - Sale | $18.00 | -4,677 | 156.3K | -3% | -$84.2K |
| D | 2026-03-03 | 2026-03-01 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | A - Grant | $0.00 | +61.3K | 161.0K | +61% | $0 |
| 2026-01-07 | 2026-01-05 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | S - Sale | $9.21 | -6,379 | 99.7K | -6% | -$58.8K | |
| 2025-07-25 | 2025-07-23 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | S - Sale | $14.02 | -7,462 | 106.1K | -7% | -$104.6K | |
| D | 2025-03-04 | 2025-03-01 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | A - Grant | $0.00 | +47.2K | 113.5K | +71% | $0 |
| D | 2024-07-24 | 2024-07-22 | NTLA | Intellia Therapeutics, Inc. | Dulac Edward J III | EVP, CFO | A - Grant | $0.00 | +66.3K | 66.3K | New | $0 |
| T | 2024-03-05 | 2024-03-04 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $7.77 | -2,447 | 101.5K | -2% | -$19.0K |
| T | 2024-01-30 | 2024-01-29 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $5.00 | -1,849 | 103.9K | -2% | -$9,245 |
| 2024-01-10 | 2024-01-09 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $4.37 | -7,028 | 105.8K | -6% | -$30.7K | |
| T | 2024-01-03 | 2024-01-02 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $3.66 | -5,182 | 112.8K | -4% | -$19.0K |
| 2023-12-19 | 2023-12-18 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $3.50 | -1,585 | 118.0K | -1% | -$5,548 | |
| 2023-08-21 | 2023-08-18 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $2.80 | -4,718 | 119.6K | -4% | -$13.2K | |
| 2023-07-06 | 2023-07-05 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $4.83 | -5,182 | 124.3K | -4% | -$25.0K | |
| 2023-01-11 | 2023-01-10 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $5.24 | -7,331 | 129.5K | -5% | -$38.4K | |
| M | 2022-08-19 | 2022-08-18 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $29.81 | -5,135 | 137.2K | -4% | -$153.1K |
| D | 2022-01-27 | 2022-01-25 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | A - Grant | $0.00 | +33.3K | 141.9K | +31% | $0 |
| M | 2022-01-13 | 2022-01-11 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $48.45 | -1,770 | 108.6K | -2% | -$85.8K |
| D | 2021-12-21 | 2021-12-20 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | M - OptEx | $35.52 | +14.4K | 126.4K | +13% | +$512.8K |
| D | 2021-12-21 | 2021-12-20 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale+OE | $60.00 | -16.0K | 110.4K | -13% | -$958.6K |
| 2021-11-22 | 2021-11-19 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | A - Grant | $0.00 | +59.5K | 111.9K | +114% | $0 | |
| D | 2021-09-30 | 2021-09-28 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | M - OptEx | $35.52 | +17.3K | 71.9K | +32% | +$615.4K |
| D | 2021-09-30 | 2021-09-28 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale+OE | $62.53 | -19.5K | 52.4K | -27% | -$1.22M |
| M | 2021-08-20 | 2021-08-19 | FATE | FATE THERAPEUTICS INC | Dulac Edward J III | CFO | S - Sale | $88.26 | -3,474 | 54.5K | -6% | -$306.6K |
Purchase Sale Sale after option exercise All abbreviations